A phase I study of stereotactic body radiotherapy with real-time tumor tracking using CyberKnife and Monte Carlo algorithm for lung tumors.
Phase 1
- Conditions
- lung tumor
- Registration Number
- JPRN-UMIN000005061
- Lead Sponsor
- Department of Radiology, Nagoya City University Graduate School of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
1.active infection needed therapy 2.fever of 38.0 degrees centigrade or higher 3.pregnancy 4.psychiatric disorder 5.steroid administration 6.Patients who are considered to be inappropriate for this study by physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method incidence of Grade 3 or higher radiation pneumonitis within 180 days after stereotactic body radiotherapy
- Secondary Outcome Measures
Name Time Method Overall survival, Progression-free survival, local progression-free survival, 3-year survival, 3 year local progression free survival, Event-free survival, 3 year local control rate, pattern of progression, Grade 2 or higher radiation pneumonitis, adverse event, severe adverse event